Vericel Corporation VCEL
Set alert
40.26 USD -2.65 -6.18%
At close · Oct 30
40.26 0.00 0.00%
After hours · Oct 30, 7:30 PM ET
40.01 Day range 43.02
29.34 52-week range 48.31
- YTD
- +11.80%
- 1 year
- +16.59%
- Open
- 43.02
- Prev close
- 42.91
- Mkt cap
- 2.06B
- Vol
- 598.74K
- Avg vol
- 512.19K
- EPS
- 0.47
- P/E
- 85.66
- Div yield
- 0.00%
More statistics
- Low
- 40.01
- High
- 43.02
- Forward P/E
- 47.56
- Beta
- 1.02
- Short ratio
- 9.42
- Inst. own
- 110.21%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 40.62
- 200-d avg
- 38.64
- 1y target
- 59.71
5Y chart
Events in this range
- Jul 31, 2025Earnings: -0.01; estimate -0.04; surprise 75%
- Nov 6, 2025Earnings: 0.1; estimate -0.02; surprise 600%
- Feb 26, 2026Earnings: 0.45; estimate 0.45; surprise 0%
- May 7, 2026Earnings: -0.12; estimate -0.15; surprise 20%
- Jul 16, 2026Rating: Truist Securities · Buy → Buy
- Jul 28, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Jul 30, 2026Earnings: 0.04; estimate -0.02894; surprise 238.22%
- Jul 31, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Jul 31, 2026Rating: Truist Securities · Buy → Buy
- Jul 31, 2026Rating: TD Cowen · Buy → Buy
- Oct 14, 2026Rating: Truist Securities · Buy → Buy
Signals (124)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 19, 2026 | 1 week ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| RSI: Overbought | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | May 25, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Oct 13, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 13, 2025 | 1 year ago |
| RSI: Oversold | Sep 22, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 14, 2025 | 1 year ago |
| RSI: Oversold | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 23, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| RSI: Oversold | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 17, 2025 | 1 year ago |
| SMA: Bearish | Feb 10, 2025 | 1 year ago |
| SMA: Bullish | Jan 27, 2025 | 1 year ago |
| SMA: Bearish | Jan 20, 2025 | 1 year ago |
| SMA: Bullish | Nov 4, 2024 | 1 year ago |
| SMA: Bullish | Nov 4, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 4, 2024 | 1 year ago |
| SMA: Bearish | Sep 2, 2024 | 2 years ago |
| SMA: Bearish | Sep 2, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 29, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 22, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| SMA: Bullish | Jun 17, 2024 | 2 years ago |
| SMA: Bearish | Jun 10, 2024 | 2 years ago |
| SMA: Bearish | May 27, 2024 | 2 years ago |
| SMA: Bullish | Apr 29, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 22, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| RSI: Overbought | Feb 12, 2024 | 2 years ago |
| SMA: Bullish | Jan 8, 2024 | 2 years ago |
| SMA: Bullish | Jan 8, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 8, 2024 | 2 years ago |
| SMA: Bearish | Jan 1, 2024 | 2 years ago |
| SMA: Bearish | Jan 1, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 25, 2023 | 2 years ago |
| SMA: Bearish | Dec 18, 2023 | 2 years ago |
| SMA: Bullish | Dec 11, 2023 | 2 years ago |
| SMA: Bullish | Dec 11, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 11, 2023 | 2 years ago |
| SMA: Bearish | Dec 4, 2023 | 2 years ago |
| SMA: Bearish | Dec 4, 2023 | 2 years ago |
| MACD: Sell Signal | Dec 4, 2023 | 2 years ago |
| SMA: Bullish | Nov 13, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 13, 2023 | 2 years ago |
| SMA: Bearish | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| SMA: Bearish | Oct 9, 2023 | 3 years ago |
| SMA: Bearish | Oct 9, 2023 | 3 years ago |
| SMA: Bullish | Sep 25, 2023 | 3 years ago |
| SMA: Bullish | Sep 11, 2023 | 3 years ago |
| SMA: Bearish | Sep 4, 2023 | 3 years ago |
| SMA: Bullish | Aug 28, 2023 | 3 years ago |
| SMA: Bearish | Aug 21, 2023 | 3 years ago |
| SMA: Bullish | Aug 14, 2023 | 3 years ago |
| SMA: Bearish | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Jul 31, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 31, 2023 | 3 years ago |
| SMA: Bullish | Apr 3, 2023 | 3 years ago |
| SMA: Bearish | Mar 13, 2023 | 3 years ago |
| SMA: Bullish | Jan 9, 2023 | 3 years ago |
| SMA: Bearish | Jan 2, 2023 | 3 years ago |
| SMA: Bullish | Dec 26, 2022 | 3 years ago |
| SMA: Bullish | Dec 12, 2022 | 3 years ago |
| SMA: Bearish | Dec 5, 2022 | 3 years ago |
| SMA: Bullish | Nov 28, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 28, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 21, 2022 | 3 years ago |
| SMA: Bearish | Nov 7, 2022 | 3 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 17, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 26, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bearish | Aug 1, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 11, 2022 | 4 years ago |
| SMA: Bullish | Jul 4, 2022 | 4 years ago |
| RSI: Oversold | Jun 13, 2022 | 4 years ago |
| SMA: Bearish | Apr 18, 2022 | 4 years ago |
| SMA: Bullish | Mar 21, 2022 | 4 years ago |
| SMA: Bearish | Mar 7, 2022 | 4 years ago |
| SMA: Bullish | Feb 21, 2022 | 4 years ago |
Key statistics
- Market cap
- 2.06B
- Enterprise value
- 2.13B
- Trailing P/E
- 85.61
- Forward P/E
- 47.56
- PEG ratio
- 0.00
- Price / sales
- 6.73
- Price / book
- 5.56
- EPS (TTM)
- 0.47
- Beta
- 1.02
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 7.91%
- Revenue (TTM)
- 306.30M
- Revenue growth
- 22.50%
- Free cash flow
- 55.54M
- Total cash
- 162.46M
- Total debt
- 93.13M
- Return on equity
- 7.16%
- Shares outstanding
- 51.21M
- Short % of float
- 13.18%
- 50-day average
- 40.62
- 200-day average
- 38.64
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 59.71 +48.3% upside
Now 40.26
- Target (low)
- 52.00
- Target (mean)
- 59.71
- Target (high)
- 72.00
Ratings (0m) 8 7 buy · 1 hold · 0 sell
- Strong buy0
- Buy7
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 0.056.
Financials — quick view
VCEL Revenue — quarterly 77.46M
VCEL Net income — quarterly 2.21M
VCEL EPS — quarterly 0.04
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 0.0575 | — | — | — |
| Jul 30, 2026 | Jun 30, 2026 | -0.02894 | 0.04 | +0.07 | +238.22% |
| May 7, 2026 | Mar 31, 2026 | -0.15 | -0.12 | +0.03 | +20.00% |
| Feb 26, 2026 | Dec 31, 2025 | 0.45 | 0.45 | 0.00 | 0.00% |
| Nov 6, 2025 | Sep 30, 2025 | -0.02 | 0.10 | +0.12 | +600.00% |
| Jul 31, 2025 | Jun 30, 2025 | -0.04 | -0.01 | +0.03 | +75.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | Truist Securities | main | Buy | Buy |
| Jul 31, 2026 | TD Cowen | main | Buy | Buy |
| Jul 31, 2026 | Truist Securities | reit | Buy | Buy |
| Jul 31, 2026 | HC Wainwright & Co. | main | Buy | Buy |
| Jul 28, 2026 | HC Wainwright & Co. | reit | Buy | Buy |
| Jul 16, 2026 | Truist Securities | main | Buy | Buy |
About Vericel Corporation
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- vcel.com
News
- Truist Securities Maintains Buy on Vericel, Lowers Price Target to $52
- TD Cowen Maintains Buy on Vericel, Raises Price Target to $58
- Truist Securities Reiterates Buy on Vericel, Raises Price Target to $58
- HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $72
- Vericel Q2 EPS $0.04 Beats $(0.03) Estimate, Sales $77.457M Beat $72.689M Estimate
- Vericel Raises FY2026 Sales Guidance from $326.000M-$336.000M to $330.000M-$340.000M vs $332.199M Est
- HC Wainwright & Co. Reiterates Buy on Vericel, Maintains $70 Price Target
- Truist Securities Maintains Buy on Vericel, Raises Price Target to $54
- HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $70
- Vericel Raises FY2026 Sales Guidance from $316.000M-$326.000M to $326.000M-$336.000M vs $323.377M Est
Your note
Sign in to keep a note on VCEL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| COLANGELO DOMINICK C | Chief Executive Officer | Conversion of Exercise of derivative security | Feb 23, 2026 | 312,446 |
| HAGEN HEIDI M. | Director | Conversion of Exercise of derivative security | Apr 28, 2026 | 35,050 |
| HALPIN MICHAEL | Chief Operating Officer | Sale | Aug 2, 2026 | 16,394 |
| HOPPER JONATHAN MARK | Officer | Sale | Jun 25, 2026 | 75,753 |
| MARA JOSEPH ANTHONY JR | Chief Financial Officer | Sale | Jun 25, 2026 | 16,009 |
| MCLAUGHLIN KEVIN F | Director | Sale | Aug 11, 2026 | 18,300 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.80% | 8,092,226 | 325.59M | Jun 29, 2026 |
| State Street Corporation | 6.43% | 3,293,975 | 132.53M | Jun 29, 2026 |
| Congress Asset Management Co | 4.98% | 2,552,066 | 102.68M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.41% | 2,255,728 | 90.76M | Jun 29, 2026 |
| Conestoga Capital Advisors, LLC | 4.07% | 2,083,832 | 83.84M | Jun 29, 2026 |
| William Blair Investment Management, LLC | 3.89% | 1,992,855 | 80.18M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 3,047,921 | 122.63M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.16% | 1,617,188 | 65.07M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.59% | 1,328,230 | 53.44M | Sep 29, 2026 |
| Conestoga Funds-Conestoga Small Cap Fund | 2.55% | 1,307,355 | 52.60M | Jun 29, 2026 |
| Professionally Managed Portfolios-Congress Small Cap Growth Fund | 2.28% | 1,165,000 | 46.87M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.15% | 1,103,424 | 44.40M | Sep 29, 2026 |